1: Where do you see KRIs and DQO playing the greatest role?
As an operational driver for Risk-Based Monitoring
As a tool to ensure third party quality oversight
For overall Data Quality Oversight in late phase studies
As a stamp of data quality
As an insurance policy for clinical studies
2: How far along is your company in using RBM?
Bought into RBM and planning how to use it in most studies
Still evaluating the various approaches
Fully embraced RBM and using it in most late phase studies
Have piloted RBM in less than 5 studies
Currently conducting an assessment of vendors